Italy In-Vitro Diagnostics Market will reach US$ 3.59 Billion in 2028, according to Renub Research. In vitro means "in glass," indicating that the tests are conducted in controlled laboratory conditions rather than within a living organism. IVD, or In Vitro Diagnostics, are medical tests performed in a lab on samples like blood or urine. They help diagnose diseases, monitor treatment progress, and provide health information.

1. Italy In-Vitro Diagnostics (IVD)
Market shall reach US$ 3.59
billion in 2028
Base Year: 2022
Market Research & Advisory

2. 2
2
Italy In-Vitro Diagnostics Market
Renub Research has recently published a report named "Italy In-Vitro Diagnostics (IVD) Market: Global Industry
Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028," providing a detailed industry analysis that
consists of market share insights. Furthermore, In addition, the report comprises competitor and regional research
and contemporary extension in the Italy In-Vitro Diagnostics (IVD) Market.
Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/italy-in-
vitro-diagnostics-market-p.php
Italy's In-Vitro Diagnostics Market shall grow at a CAGR of 6.66% during the 2022-2028. In-Vitro Diagnostics (IVD)
refers to medical devices, reagents, and systems used for diagnostic testing outside the human body. It plays a
crucial role in healthcare by detecting and diagnosing diseases, monitoring treatment response, and assessing
overall health.
The Italy market for in-vitro diagnostics (IVD) is facing escalating challenges. Italy is experiencing a surge in the
prevalence of diverse diseases, encompassing cancer, autoimmune diseases, myocardial infarctions, arrhythmia,
and inflammatory conditions.
2
https://www.renub.com

3. 3
3
Italy In-Vitro Diagnostics Market
This escalating trend in disease incidence is projected to propel the demand for IVD testing in the country. Breast
cancer, prostate cancer, colorectal cancer, lung cancer, and bladder cancer rank among the most frequently
diagnosed cancers in Italy. Additionally, as per the International Diabetes Federation, Italy had an estimated 4.4
million cases of diabetes in its adult population in 2022.
Unhealthy dietary habits, high tobacco and alcohol consumption, obesity, and sedentary lifestyles contribute to the
mounting prevalence of these targeted diseases in Italy. Furthermore, alterations in regulatory policies are expected
to fuel the growth of the IVD market in the forthcoming years. In September 2022, the Italy government revised its
national regulatory framework concerning IVD products, with the aim of enhancing the safety standards of such
products within the country. These policy changes are anticipated to ensure a higher level of safety for IVD products
available in Italy.
According to the 2023 report by Renub Research, individuals who are 65 years and older account for over
24 Percent of Italy's total population. Furthermore, the report reveals that more than 23.5 million people in
Italy are affected by at least one chronic disease, and a considerable portion of them suffer from two or
more chronic conditions.
3
https://www.renub.com

4. 4
4
Italy In-Vitro Diagnostics Market
However, stringent regulations and reimbursement policies in the Italy in-vitro diagnostics (IVD) market pose
challenges to the widespread adoption and accessibility of advanced diagnostic technologies.
The services segment will continue thriving in the Italy in-vitro diagnostics (IVD) market.
The continuous expansion of services in the in-vitro diagnostics (IVD) market in Italy can be attributed to various
factors. One key driver is the increasing demand for specialized and personalized diagnostic services, fuelled by the
growing prevalence of chronic diseases and the need for targeted treatment approaches. Technological
advancements have played a crucial role in enhancing the capabilities and scope of diagnostic services, offering
more accurate and comprehensive testing options. The emphasis on preventive and personalized healthcare has
also led to a rising demand for screening and monitoring services. Additionally, the aging population has contributed
to the growth of services in the IVD market, necessitating the provision of geriatric healthcare services. The
integration of digital technologies and telemedicine has further improved the accessibility of diagnostic services,
enabling remote consultations and faster results delivery. Moreover, favourable government policies and
reimbursement frameworks have incentivized the utilization of services, supporting the overall growth of the market.
4
https://www.renub.com

5. 5
5
Italy In-Vitro Diagnostics Market
Products–the Italy in-vitro diagnostics (IVD) Market breakup from 3 Viewpoints:
1. Services 2. Instruments 3. Reagents
PCR tests shall maintain their dominant market share in the Italy in-vitro diagnostics market.
PCR (Polymerase Chain Reaction) is widely recognized for its exceptional sensitivity and specificity in detecting
pathogens and genetic material. Its accuracy and reliability make it a preferred choice in various fields such as
genetics, forensics, and infectious disease diagnosis. PCR tests can be rapidly scaled up, providing quick results
and offering flexibility across different testing platforms. With a robust track record of diagnostic validity and
regulatory approval, PCR tests inspire confidence among healthcare providers. Furthermore, the COVID-19
pandemic has played a significant role in accelerating the widespread adoption of PCR tests, solidifying their
substantial market share in the in-vitro diagnostics market in Italy.
5
https://www.renub.com

6. 6
6
Italy In-Vitro Diagnostics Market
Test types - the Italy in-vitro diagnostics Market breakup from 11 Viewpoints:
1. ELISA & CLIA 2. PCR
3. Rapid Test 4. Fluorescence Immunoassays (FIA)
5. In Situ Hybridization 6. Transcription Mediated Amplification
7. Sequencing 8. Colorimetric Immunoassay
9. Radioimmunoassay (RIA) 10. Isothermal Nucleic Acid Amplification Technology
11. Others
The application of the Italy in-vitro diagnostics market in infectious diseases is experiencing rapid growth.
Italy susceptibility to the transmission of infectious diseases has been heightened by global travel, migration, and
changing demographics. The emergence of antimicrobial resistance further underscores the critical role of accurate
diagnostics in effective treatment. Outbreaks and epidemics, including influenza, measles, and COVID-19, have
created a higher demand for rapid and precise diagnostics to enable timely intervention.
6
https://www.renub.com

7. 7
7
Italy In-Vitro Diagnostics Market
Increased awareness and proactive screening initiatives have also played a role in driving market growth. Moreover,
advancements in molecular diagnostics and the availability of rapid point-of-care testing have enhanced the
accuracy and capabilities of infectious disease diagnostics, contributing to the expansion of the in-vitro diagnostics
(IVD) market in Italy.
Application - the Italy in-vitro diagnostics (IVD) Market breakup from 8 Viewpoints:
1. Infectious Diseases 2. Diabetes 3. Cardiology
4. Oncology 5. Nephrology 6. Autoimmune Diseases
7. Drug Testing 8. Others
The forecast period anticipates a profitable growth of Molecular Diagnostics/Genetics in the Italy in-vitro
diagnostics market.
Italy in-vitro diagnostics (IVD) market is poised for profitable growth, particularly in the field of Molecular
Diagnostics/Genetics. The forecast period anticipates significant advancements and increased adoption of
molecular diagnostic techniques in Italy.
7
https://www.renub.com

8. 8
8
Italy In-Vitro Diagnostics Market
This growth can be attributed to the rising demand for personalized medicine, the increasing prevalence of chronic
diseases, and the expanding applications of molecular diagnostics in disease diagnosis, monitoring, and treatment.
These factors are expected to drive market expansion and present lucrative opportunities for stakeholders in the
Italian IVD market.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=italy-in-
vitro-diagnostics-market-p.php
Technology - the Italy in-vitro diagnostics (IVD) Market breakup from 7 Viewpoints:
1. Immunoassay 2. Clinical Chemistry
3. Molecular Diagnostics/Genetics 4. Hematology
5. Microbiology 6. Coagulation
7. Others
8
https://www.renub.com

9. 9
9
Italy In-Vitro Diagnostics Market
Hospitals maintain a dominant position in the Italy in-vitro diagnostics market.
Hospitals play a leading role in the Italy in-vitro diagnostics (IVD) market, leveraging their extensive healthcare
services and seamless integration of diagnostics with various specialties. With well-established infrastructure,
abundant resources, and skilled personnel, hospitals are well-equipped to provide comprehensive IVD operations.
As primary care providers and referral centers, hospitals offer various medical services, facilitating accurate
diagnosis and interpretation of IVD test results. Furthermore, hospitals benefit from favourable reimbursement and
funding mechanisms, ensuring adherence to rigorous regulatory standards for patient safety and test accuracy.
End-User - the Italy in-vitro diagnostics (IVD) Market breakup from 4 Viewpoints:
1. Hospitals 2. Laboratories 3. Home – Care 4. Others
Competitive Landscape.
Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher
Scientific, and Sysmex Corporation are among the prominent companies in the Italy in-vitro diagnostics market.
9
https://www.renub.com

10. 10
10
Italy In-Vitro Diagnostics Market
Company have been covered from 3 Viewpoints:
• Overview • Recent Development • Revenue
Company Analysis:
1. Roche Diagnostics 2. Abbott Diagnostics 3. Siemens Healthineers
4. Danaher Corporation 5. Thermo Fisher Scientific 6. Sysmex Corporation
10
https://www.renub.com

11. S
O U T
A U
B
11
https://www.renub.com
Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in
Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy,
organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000
syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to
EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings
and perspectives across a wide range of markets.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: https://linkedin.com/company/renub-research